RNU7-161P

Across TCGA pan-cancer cohorts, RNU7-161P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-161P data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher RNU7-161P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-161P expression acts as an unfavorable survival marker.

GBM, SKCM, and THCA are the cancer types where RNU7-161P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Tertile	All	0.058	0.416	<.001	36	view →
SKCM	DFS	Tertile	All	0.188	0.621	.016	36	view →
THCA	DFS	Tertile	All	0.060	0.909	<.001	27	view →
SARC	DFS	Tertile	All	0.173	0.521	.003	27	view →
KIRC	DFS	Tertile	All	0.239	0.636	.024	24	view →
ESCA	DFS	Tertile	All	0.152	0.708	.011	18	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
MESO	OS	Tertile	All	0.169	0.556	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-161P–GBM (OS)

Open the GBM breakdown →